Traditionally, bleeding has been the primary cause of death in war zones. According to recent studies, a significant portion of battlefield fatalities are entirely preventable. Notably, more than 90% of casualties die before reaching the field hospital, making rapid bleeding control on the battlefield crucial. Over the past decade, several agents and devices have been developed to aid in bleeding control. We aimed to review the various aspects of known hemostatic agents, particularly their effectiveness in military applications. For this purpose, a comprehensive search was conducted in electronic databases (PubMed, Web of Science, Scopus, and Google Scholar) using keywords including military, war, battlefield, trauma, bleeding, hemostatic, bandage, and dressing. Hemostatic agents can act through a variety of mechanisms, including wound contraction, concentration of coagulation factors, adhesion to tissues, and release of coagulation factors at the bleeding site. The most important characteristics of an ideal hemostatic agent for controlling urban and battlefield bleeding include the ability to stop bleeding immediately, no need for mixing or processing before use, ease of use, lightweight and durable nature, long shelf life, acceptable safety, and cost-effectiveness. Additionally, it should be biodegradable, non-toxic, easy to remove, and flexible. Since 2003, various compounds such as Chitosan, Zeolite, Kaolin, Fibrin, and Smectite have been used to produce hemostatic products including HemCon, Celox, ChitoFlex, QuikClot, Combat Gauze, FSD, and WoundStat. Some of these products have received FDA approval, particularly for battlefield use. However, achieving the ideal product still requires further studies in the future.